FASN and metabolic dysfunction-associated steatotic liver disease: Sorting nexin 8 (SNX8) has emerged as a potential therapeutic target for NAFLD because it directly binds to FASN and boosts FASN degradation by facilitating the tripartite motif-containing 28 (TRIM28)-FASN interaction [65].